SA
CME icon

Strategic Advocates’s CME Group CME Stock Holding History

Strategic Advocates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Buy
58
+21
+57% +$5.81K 0.05% 148
2026
Q1 		$10.9K Sell
37
-1,739
-98% -$517K 0.05% 153
2025
Q4 		$490K Sell
1,776
-154
-8% -$41.8K 0.13% 76
2025
Q3 		$521K Buy
1,930
+23
+1% +$6.26K 0.14% 78
2025
Q2 		$526K Buy
1,907
+57
+3% +$15.5K 0.16% 74
2025
Q1 		$491K Sell
1,850
-358
-16% -$88.3K 0.17% 68
2024
Q4 		$513K Buy
2,208
+382
+21% +$87.8K 0.17% 63
2024
Q3 		$403K Buy
1,826
+415
+29% +$85.9K 0.14% 84
2024
Q2 		$277K Buy
1,411
+152
+12% +$31.4K 0.11% 97
2024
Q1 		$271K Buy
+1,259
New +$264K 0.1% 104

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Strategic Advocates's CME Position: Q2 2026 in Review

Strategic Advocates increased its CME Group (CME) stake by 57% in Q2 2026, buying an estimated $5.81K and bringing the position to 58 shares worth $12.8K. The position accounts for 0.05% of the portfolio, ranked #148.

Strategic Advocates first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $526K in Q2 2025. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Strategic Advocates held 58 shares of CME Group worth $12.8K as of Q2 2026.
  • Strategic Advocates bought 21 CME Group shares in Q2 2026, an estimated $5.81K.
  • CME Group made up 0.05% of Strategic Advocates's portfolio in Q2 2026, its #148 holding.
  • Strategic Advocates first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • Strategic Advocates's CME Group position peaked at $526K in Q2 2025.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.